On February 20th, according to the official WeChat account of TUS-PHARMA, the "2025 Medical Artificial Intelligence and Precision Diagnosis Development Forum" was held at Ruijin Hospital in Shanghai on the afternoon of February 18th. This grand event gathered numerous industry experts, scholars, and corporate representatives to witness the launch of the "RuiPath" large model for pathology. Hengdao Medical has been assisting the pathology department of Ruijin Hospital in the construction of a digital pathology department since 2021, and has taken the lead in the country to establish an "end-to-end full-process digital intelligent pathology system," accumulating a library of millions of digital pathology slides. Hengdao Medical's WisPath® full-process intelligent digital pathology system provides a solid data foundation and technical support for the construction of the "RuiPath" large model for pathology. The WisPath® system will work together with the "RuiPath" large model for pathology in the future to help realize the "new domestic pathology large model" intelligent platform, truly becoming the "divine assistant" for pathologists
TUS-PHARMA: The subsidiary Hengdao Pathology, in which it holds shares, assists Ruijin Hospital in collaborating with Huawei to launch the "Ruizhi Pathology Large Model."
Recommended Readings
LongbridgeAI
